Putting evidence into practice®: Evidence-based interventions to prevent and manage Anorexia

Clinical Journal of Oncology Nursing

Volumn 13, Issue 1, 2009, Pages 95-102

  Adams, Lynn A ^a   Shepard, Nancy ^b   Caruso, Rose Ann ^a   Norling, Martha J ^c   Belansky, Heather ^d   Cunningham, Regina S ^e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b California Cancer Inc   (United States)

^c California Cancer Care   (United States)

^d ONCOLOGY NURSING SOCIETY   (United States)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIA; CALORIC INTAKE; CLINICAL PRACTICE; COUNSELING; EVIDENCE BASED MEDICINE; HUMAN; METHODOLOGY; NEOPLASM; NURSING; NUTRITIONAL STATUS; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; REVIEW;

ANOREXIA; COUNSELING; ENERGY INTAKE; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; NUTRITIONAL STATUS; ONCOLOGIC NURSING; PHYSICIAN'S PRACTICE PATTERNS;

EID: 70349260557     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/09.CJON.95-102     Document Type: Article

References (39)

1. Adams, L., Cunningham, R., Shepard, N., Caruso, R.A., Norling, M.J., & Belansky, H. (2008). Oncology Nursing Society Putting Evidence Into Practice®: Anorexia. Retrieved January 16, 2008, from http://www.ons.org/outcomes/volume4/anorexia/pdf/ ShortCard_Anorexia.pdf
2. Berenstein, E.G., & Ortiz, Z. (2005). Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database of Systematic Reviews, 2(2), CD004310.
3. Brown, J.K. (2002). A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncology Nursing Forum, 29(3), 517-530.
4. Bruera, E., Neumann, C.M., Pituskin, E., Calder, K., Ball, G., & Hanson, J. (1999). Thalidomide in patients with cachexia due to terminal cancer: Preliminary report. Annals of Oncology, 10(7), 857-859.
5. Bruera, E., Strasser, F., Palmer, J.L., Willey, J., Calder, K., Amyotte, G., et al. (2003). Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: A doubleblind, placebo-controlled study. Journal of Clinical Oncology, 21(1), 129-134.
6. Cangiano, C., Laviano, A., Meguid, M.M., Mulieri, M., Conversano, L., Preziosa, I., et al.(1996). Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. Journal of the National Cancer Institute, 88(8), 550-552.
7. Celegene Corporation. (2007). Thalomid®. Retrieved July 31, 2008, from http://www.thalomid.com/thalomid_pi.aspx
8. Daneryd, P., Svanberg, E., Korner, U., Lindholm, E., Sandstrom, R., Brevinge, H., et al. (1998). Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: A randomized prospective study. Cancer Research, 58(23), 5374-5379.
9. Desport, J.C., Gory-Delabaere, G., Blanc-Vincent, M.P., Bachmann, P., Beal, J., Benamouzig, R., et al. (2003). Standards, options and recommendations for the use of appetite stimulants in oncology (2000). British Journal of Cancer, 89(Suppl. 1), S98-S100.
10. DeWys, W.D., Begg, C., Lavin, P.T., Band, P.R., Bennett, J.M., Bertino, J.R., et al. (1980). Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. American Journal of Medicine, 69(4), 491-497.
11. Fearon, K.C., Barber, M.D., Moses, A.G., Ahmedzai, S.H., Taylor, G.S., Tisdale, M.J., & Murray, G.D. (2006). Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. Journal of Clinical Oncology, 24(21), 3401-3407.
12. Gagnon, B., & Bruera, E. (1998). A review of the drug treatment of cachexia associated with cancer. Drugs, 55(5), 675-688.
13. Goldberg, R.M., Loprinzi, C.L., Mailliard, J.A., O'Fallon, J.R., Krook, J.E., Ghosh, C., et al. (1995). Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. Journal of Clinical Oncology, 13(11),2856-2859.
14. Gordon, J.N., Trebble, T.M., Ellis, R.D., Duncan, H.D., Johns, T., & Goggin, P.M. (2005). Thalidomide in the treatment of cancer cachexia: A randomized placebo controlled trial. Gut, 54(4), 540-545.
15. Inoue, A., Yamada, Y., Matsumura, Y., Shimada, Y., Muro, K., Gotoh, M., et al. (2003). Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan. Supportive Care in Cancer, 11(8), 528-532.
16. Jatoi, A., Dakhil, S.R., Nguyen, P.L., Sloan, J.A., Kugler, J.W., Rowland, K.M., Jr., et al. (2007). A placebo-controlled double blind trial of etanercept for cancer anorexia/weight loss syndrome. Cancer, 110(6), 1396-1403.
17. Jatoi, A., Rowland, K., Loprinzi, C.L., Sloan, J.A., Dakhil, S.R., MacDonald, N., et al. (2004). An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer associated wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort. Journal of Clinical Oncology, 22(12), 2469-2476.
18. Jatoi, A., Windschitl, H.E., Loprinzi, C.L., Sloan, J.A., Dakhil, S.R., Mailliard, J.A., et al. (2002). Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A North Central Cancer Treatment Group study. Journal of Clinical Oncology, 20(2), 567-573.
19. Kardinal, C.G., Loprinzi, C.L., Schaid, D.J., Hass, A.C., Dose, A.M., Athmann, L.M., et al. (1990). A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer, 65(12), 2657-2662.
20. Lai, J., Cella, D., Peterman, A., Barocas, J., & Goldman, S. (2005). Anorexia/cachexia-related quality of life for children with cancer. Cancer, 104(7), 1531-1539.
21. Lambert, D.M. & Fowler, C.J. (2005). The endocannabinoid system: Drug targets, lead compounds, and potential therapeutic applications. Journal of Medicinal Chemistry, 48(16), 5059-5087.
22. Laviano, A., Meguid, M.M., & Fanelli, F.R. (2006). Anorexia. In G. Montovani, S.D. Anker., A. Inui, J.E. Morley, F. Rossi Fanelli, D. Scevols, et al. (Eds.), Cachexia and wasting: A modern approach (pp. 139-148). Springer: Milan.
23. Laviano, A., & Rossi-Fanelli, F. (2003). Pathogenesis of cancer anorexia: Still doubts after all these years? Nutrition, 19(1), 67-68.
24. Lissoni, P., Chilelli, M., Villa, S., Cerizza, L., & Tancini, G. (2003). Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: A randomized trial. Journal of Pineal Research, 35(1), 12-15.
25. Lissoni, P., Paolorossi, F., Tancini, G., Barni, S., Ardizzoia, A., Brivio, F., et al. (1996). Is there a role for melatonin in the treatment of neoplastic cachexia? European Journal of Cancer, 32(8), 1340-1343.
26. Loprinzi, C.L., Kugler, J.W., Sloan, J.A., Mailliard, J.A., Krook, J.E., Wilwerding, M.B., et al. (1999). Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. Journal of Clinical Oncology, 17(10), 3299-3306.
27. Lundholm, K., Daneryd, P., Bosaeus, I., Koerner, U., & Lindholm, E. (2004). Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignancy disease: Effects on survival, metabolism, and function. Cancer, 100(9), 1967-1977.
28. Maltoni, M., Nanni, O., Scarpi, E., Rossi, D., Serra, P., & Amadori, D. (2001). High-dose progestins for the treatment of cancer anorexiacachexia syndrome: A systematic review of randomised clinical trials. Annals of Oncology, 12(3), 289-300.
29. Moertel, C.G., Schutt, A.J., Reitemeier, R.J., & Hahn, R.G. (1974). Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer, 33(6), 1607-1609.
30. Neary, N.M., Small, C.J., Wren, A.M., Lee, J.L., Druce, M.R., Palmieri, C., et al. (2004). Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 89(6), 2832-2836.
31. Pawlowski, G.J. (1975). Cyproheptadine: Weight-gain and appetite stimulation in essential anorexic adults. Current Therapeutic Research, Clinical and Experimental, 18(5), 673-678.
32. Priovano, M., Maltoni, M., Nanni, O., Marinari, M., Indelli, M., Zaninetta, G., et al. (1999). A new palliative score: A first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. Journal of Pain and Symptom Management, 17(4), 231-239.
33. Ravasco, P., Monteiro-Grillo, I., Vidal, P.M., & Camilo, P.E. (2005). Dietary counseling improves patient outcomes: A prospective, randomized, controlled trial, in colorectal cancer patients undergoing radiotherapy. Journal of Clinical Oncology, 23(7), 1431-1438.
34. Strasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., et al. (2006). Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. Journal of Clinical Oncology, 24(21) 3394-4000.
35. Strasser, F., Lutz, T.A., Maeder, M.T., Thuerlimann, B., Bueche, D., Tschop, M., et al. (2008). Safety, tolerability, and pharmacokinetics of intravenous ghrelin for cancer related anorexia/cachexia: a randomized, placebo-controlled, double-blind, double-crossover study. British Journal of Cancer, 98(2), 300-308.
36. ®: Evidence-based interventions to prevent, manage, and treat chemotherapy-induced nausea and vomiting. Clinical Journal of Oncology Nursing, 11(1), 69-78
37. Tisdale, M.J. (2003). Pathogenesis of cancer cachexia. Supportive Oncology, 1(3), 159-168.
38. Willox, J.C., Corr, J., Shaw, J., Richardson, M., Calman, K.C., & Drennan, M. (1984). Prednisolone as an appetite stimulant in patients with cancer. BMJ, 288(6410), 27.
39. Yavuzsen, T., Davis, M.P., Walsh, D., Legrand, S., & Lagman, R. (2005). Systematic review of the treatment of cancer-associated anorexia and weight loss. Journal of Clinical Oncology, 23(33), 8500-8511